Maven Securities Adds $866,000 Stake in SOPHiA Genetics
Maven Securities LTD acquired 150,000 shares of SOPHiA GENETICS SA, worth about $866,000, via its latest 13F filing. Quadrature Capital also took a smaller new position, while other funds reported stakes. BTIG Research raised its price target to $9 and reiterated a buy rating, and SOPHiA GENETICS stock rose about 3.3%, despite insider sales totaling roughly $2.15 million over three months.